| 中文名 | 6-氟-1-甲基-3,1-苯并噁嗪-2,4-二酮 |
|---|---|
| 英文名 | 6-fluoro-1-methyl-3,1-benzoxazine-2,4-dione |
| 中文别名 | 6-氟-1-甲基-2H-苯并[D][1,3]噁嗪-2,4(1H)-二酮 |
| 英文别名 |
6-fluoro-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione
2H-3,1-Benzoxazine-2,4(1H)-dione, 6-fluoro-1-methyl N-methyl 4-fluoroisatoic anhydride 6-Fluoro-1-methyl-2H-benzo[d][1,3]oxazine-2,4(1H)-dione 5-fluoro N-methylisatoic anhydride 6-Fluoro-1-methyl-3,1-benzoxazine-2,4-dione |
| 分子式 | C9H6FNO3 |
|---|---|
| 分子量 | 195.14700 |
| 精确质量 | 195.03300 |
| PSA | 52.21000 |
| LogP | 0.63080 |
|
~55%
61352-46-3 |
| 文献:AVANIR PHARMACEUTICALS Patent: WO2004/74218 A2, 2004 ; Location in patent: Page 108 ; |
|
~65%
61352-46-3 |
| 文献:Guan, Zheng-Hui; Chen, Ming; Ren, Zhi-Hui Journal of the American Chemical Society, 2012 , vol. 134, # 42 p. 17490 - 17493,4 |
|
~%
61352-46-3 |
| 文献:Joensson, Stig; Andersson, Gunnar; Fex, Tomas; Fristedt, Tomas; Hedlund, Gunnar; Jansson, Karl; Abramo, Lisbeth; Fritzson, Ingela; Pekarski, Olga; Runstroem, Anna; Sandin, Helena; Thuvesson, Ingela; Bjoerk, Anders Journal of Medicinal Chemistry, 2004 , vol. 47, # 8 p. 2075 - 2088 |